Welcome to the International Gliomatosis Cerebri Platform
Our mission is to support world-wide collaboration among physicians, researchers, patients, and families towards finding a cure for gliomatosis cerebri.
What is Gliomatosis Cerebri?
Gliomatosis cerebri (GC) is a pattern of extensive central nervous system disease involvement that may occur in any diffuse infiltrative glioma subtype. Approximately 40 people are diagnosed per year. Outcomes are poor, with a five-year survival rate of only 18.8%. Very little is understood about how, or why, some gliomas spread this way.
Our program is run by an international network of experts studying and treating GC. We are currently a center of communication for translational scientists, and we intend to become a central resource of clinical and biological information from GC patients from across the world.
In the future, we aim to:
Facilitate understanding of GC tumorigenesis as it relates to other patterns of disease spread
Use our understanding to develop novel therapies, approaches and clinical trials for GC
Our long-term goal is to establish and maintain a highly collaborative, global research infrastructure, dedicated to pre-clinical and clinical projects related to GC.
